Archive for: Regulation

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Prescription Drug: Regulation

CMS Releases Final Part D Rule

On May 16, 2018, CMS released the final Part D and Medicare Advantage rule aimed at lowering drug prices.

POST

Prescription Drug: Regulation

CMS Issues Final Rule on Drug Pricing Transparency

The Centers for Medicare and Medicaid Services (CMS) released the Final Rule on requiring list prices to be included in direct-to-consumer television advertisements for prescription drug that are reimbursable under Medicare or Medicaid. List price is defined as the wholesale acquisition cost (WAC) for a “typical 30-day regimen or for a typical course of treatment”…

EXTERNAL LINK

Prescription Drug: Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

CMS issues pair of final rules addressing line item extension drugs.

POST

beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope